A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.

This single arm study will assess the efficacy and safety of loading doses of intravenous Bondronat in patients with breast cancer and malignant bone disease experiencing moderate to severe bone pain....

Lead sponsor: Hoffmann-La Roche•6 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 3

A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease

NCT02561039 · Pain; Bone Neoplasms; Neoplasm Metastasis

COMPLETEDPhase 3

A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer

NCT02716792 · Pain; Bone Neoplasms; Neoplasm Metastasis

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 22, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment13

Start dateJan 2008

Last updatedJan 22, 2014

Condition

Pain; Bone Neoplasms; Neoplasm Metastasis

Locations shown

Ankara

Istanbul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 22, 2014Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions